BR0112725A - Composição de verniz antimicótico para unha - Google Patents

Composição de verniz antimicótico para unha

Info

Publication number
BR0112725A
BR0112725A BR0112725-0A BR0112725A BR0112725A BR 0112725 A BR0112725 A BR 0112725A BR 0112725 A BR0112725 A BR 0112725A BR 0112725 A BR0112725 A BR 0112725A
Authority
BR
Brazil
Prior art keywords
nail polish
polish composition
antimicotic
composition
carboxyalkylchitosans
Prior art date
Application number
BR0112725-0A
Other languages
English (en)
Other versions
BRPI0112725B8 (pt
BRPI0112725B1 (pt
Inventor
Federico Mailland
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of BR0112725A publication Critical patent/BR0112725A/pt
Publication of BRPI0112725B1 publication Critical patent/BRPI0112725B1/pt
Publication of BRPI0112725B8 publication Critical patent/BRPI0112725B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Abstract

"COMPOSIçãO DE VERNIZ ANTIMICóTICO PARA UNHA". A presente invenção refere-se a uma composição compreendendo: a) pelo menos um agente antimicótico e b) pelo menos um agente de formação de película em que o componente b) é um derivado de quitosana selecionado a partir de hidroxialquilquitosanas e carboxialquilquitosanas, e ao seu uso como um verniz para unha. A presente invenção está ainda direcionada ao uso de um agente de formação de película solúvel em água a partir de hidroxialquilquitosanas e carboxialquilquitosanas como um aditivo em um verniz para unha.
BRPI0112725A 2000-07-24 2001-07-18 composição de verniz para unhas. BRPI0112725B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035991A DE10035991A1 (de) 2000-07-24 2000-07-24 Nagellackzusammensetzung
PCT/EP2001/008311 WO2002007683A1 (en) 2000-07-24 2001-07-18 Antimicotic nail varnish composition

Publications (3)

Publication Number Publication Date
BR0112725A true BR0112725A (pt) 2003-09-02
BRPI0112725B1 BRPI0112725B1 (pt) 2015-08-11
BRPI0112725B8 BRPI0112725B8 (pt) 2021-05-25

Family

ID=7650015

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0112725A BRPI0112725B8 (pt) 2000-07-24 2001-07-18 composição de verniz para unhas.

Country Status (28)

Country Link
US (1) US7033578B2 (pt)
EP (1) EP1303249B1 (pt)
JP (3) JP4170751B2 (pt)
KR (1) KR100530263B1 (pt)
CN (2) CN1307971C (pt)
AT (1) ATE261296T1 (pt)
AU (1) AU2001272551A1 (pt)
BG (1) BG65953B1 (pt)
BR (1) BRPI0112725B8 (pt)
CA (1) CA2416823C (pt)
CZ (1) CZ295221B6 (pt)
DE (2) DE10035991A1 (pt)
DK (1) DK1303249T3 (pt)
ES (1) ES2215918T3 (pt)
HK (1) HK1053067A1 (pt)
HR (1) HRP20030037B1 (pt)
HU (1) HU228525B1 (pt)
IL (4) IL154078A0 (pt)
ME (1) ME00508B (pt)
MX (1) MXPA03000764A (pt)
PL (1) PL202741B1 (pt)
PT (1) PT1303249E (pt)
RS (1) RS50213B (pt)
RU (1) RU2245715C2 (pt)
SI (1) SI1303249T1 (pt)
SK (1) SK285949B6 (pt)
TR (1) TR200400612T4 (pt)
WO (1) WO2002007683A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020089279A (ko) * 2002-11-06 2002-11-29 전상문 운데실렌산 용액
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
US20060251593A1 (en) * 2005-04-07 2006-11-09 Work By Docs, Inc. Colored nail enamel treatment
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
CN100346770C (zh) * 2005-11-08 2007-11-07 江南大学 一种水溶性指甲油的制备方法
US20090215888A1 (en) * 2006-03-02 2009-08-27 Singh Jagat Topical nail formulation
CN101002823B (zh) * 2006-11-06 2011-01-05 姜瑞菊 一种治疗甲真菌病的外用制剂
EP1958639A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans for the treatment of nail inflammatory diseases
US10201490B2 (en) 2007-02-14 2019-02-12 Polichem Sa Use of chitosans for the treatment of nail inflammatory diseases
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
US8747832B2 (en) * 2007-04-12 2014-06-10 Rutgers, The State University Of New Jersey Biodegradable polyanhydrides with natural bioactive molecules
EP2222307A1 (en) * 2007-11-20 2010-09-01 Galderma S.A. Use of amorolfine for treating a nail disease by iontophoresis
EP2153836A1 (en) * 2008-08-04 2010-02-17 Polichem S.A. Film-forming liquid formulations for drug release to hair and scalp
EP2116237A1 (en) 2008-08-05 2009-11-11 Polichem SA Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
CN101836940B (zh) * 2009-03-19 2012-05-02 蒋和平 水溶性高硬度抗菌指甲油及其制备方法
KR100979347B1 (ko) * 2009-03-25 2010-08-31 삼일제약주식회사 항진균 조성물
US20150342871A1 (en) * 2009-12-23 2015-12-03 Nuvo Research Inc. Highly permeating terbinafine formulation
EP2544659A2 (en) * 2009-12-23 2013-01-16 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
JP5240479B2 (ja) * 2010-03-12 2013-07-17 玲奈 山▲崎▼ 爪化粧料
ES2369101B2 (es) 2010-05-07 2012-08-02 Universidade De Santiago De Compostela Sistema farmacéutico acuoso para la administración de fármacos en las uñas.
RU2432158C1 (ru) * 2010-07-28 2011-10-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактический бактерицидный лак для обработки ногтей
ES2442973B1 (es) * 2012-05-30 2014-11-19 Universidad De Alicante Composición para su uso como agente antifúngico
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
EP2845597A1 (en) 2013-09-10 2015-03-11 Polichem S.A. Hydroxypropyl chitosan for the treatment of onychomycosis
EP2910245A1 (en) * 2014-02-21 2015-08-26 Polichem SA Topical antifungal composition for treating onychomycosis
EP2952208A1 (en) 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalcoholic system for nail treatment
KR101777408B1 (ko) * 2014-10-24 2017-09-11 인제대학교 산학협력단 알로에 추출물을 포함하는 매니큐어 조성물
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US20240100004A9 (en) * 2015-08-05 2024-03-28 Cmpd Licensing, Llc Topical compositions and methods of formulating same
AR108116A1 (es) 2016-04-11 2018-07-18 Biolab Sanus Farmaceutica Ltda Composición dermocosmética, proceso de producción de la composición tópica, método para fortalecimiento de uñas frágiles y uso de la composición
CN105943549A (zh) * 2016-05-10 2016-09-21 赫尔森江苏医药有限公司 一种成膜抗菌治灰指甲剂及其制作工艺
RU2674765C2 (ru) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Антигрибковая композиция эвтектического типа (варианты)
CN106726750A (zh) * 2016-12-09 2017-05-31 李晓光 一种环保抑菌护甲油及其制备方法
CN106580927A (zh) * 2017-02-17 2017-04-26 中国药科大学 一种环吡酮胺喷膜剂及其制备方法
BE1024559B1 (nl) * 2017-02-21 2018-04-05 Purna Pharmaceuticals Nv Werkwijze voor het maken van een verstuifbare emulsie omvattende een corticosteroïde, een aminoglycoside en een zuur
CN112888443A (zh) * 2018-08-01 2021-06-01 爱迪克斯-欧有限公司 用于其在治疗指或趾甲疾病中的使用和/或用于加速指或趾甲生长的具有延长的作用持续时间的可注射组合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57180602A (en) * 1981-04-30 1982-11-06 Nippon Soda Co Ltd Production of water-soluble chitosan derivative and film-forming agent comprising same
JPS597117A (ja) * 1982-07-02 1984-01-14 Teijin Ltd キトサン類を用いた製剤
DE3687458T2 (de) * 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
DE3723811A1 (de) * 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
DE3903797A1 (de) * 1989-02-09 1990-08-16 Hoechst Ag Verfahren zur herstellung von aktivierten chitosanen und deren verwendung bei der herstellung von chitosanderivaten
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
JPH05339152A (ja) * 1992-06-09 1993-12-21 Nippon Soda Co Ltd 皮膚病変局所投与薬剤含有キトサン誘導体フィルム剤
US5420197A (en) * 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
FR2718637A1 (fr) * 1994-04-15 1995-10-20 Oreal Composition cosmétique à appliquer sur l'ongle.
JP3161908B2 (ja) * 1994-06-16 2001-04-25 大日精化工業株式会社 化粧品組成物及びその製造方法
SE9604610D0 (sv) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
CA2343284C (en) * 1998-09-10 2008-11-18 Ipr-Institute For Pharmaceutical Research Ag Topical application products
DE19841796A1 (de) 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden
US5968485A (en) * 1998-10-16 1999-10-19 The Procter & Gamble Company UV protection compositions
DE19922230A1 (de) * 1999-05-14 2000-11-16 Cognis Deutschland Gmbh Kosmetische und/oder pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
IL154078A (en) 2010-02-17
CN1449273A (zh) 2003-10-15
RU2245715C2 (ru) 2005-02-10
DE60102302T2 (de) 2004-07-29
IL193224A0 (en) 2009-02-11
BG65953B1 (bg) 2010-07-30
DE10035991A1 (de) 2002-02-14
HK1053067A1 (en) 2003-10-10
CA2416823A1 (en) 2002-01-31
BRPI0112725B8 (pt) 2021-05-25
CA2416823C (en) 2008-02-12
CN1679472A (zh) 2005-10-12
ATE261296T1 (de) 2004-03-15
SI1303249T1 (en) 2004-08-31
HRP20030037B1 (en) 2005-06-30
KR20030036637A (ko) 2003-05-09
HU228525B1 (en) 2013-03-28
BG107493A (bg) 2004-08-31
PL363070A1 (en) 2004-11-15
JP2008044957A (ja) 2008-02-28
PL202741B1 (pl) 2009-07-31
HRP20030037A2 (en) 2004-02-29
TR200400612T4 (tr) 2004-04-21
ES2215918T3 (es) 2004-10-16
JP4170751B2 (ja) 2008-10-22
CZ2003217A3 (cs) 2003-06-18
CN1200673C (zh) 2005-05-11
CN1307971C (zh) 2007-04-04
KR100530263B1 (ko) 2005-11-22
WO2002007683A1 (en) 2002-01-31
EP1303249A1 (en) 2003-04-23
JP2007153910A (ja) 2007-06-21
RS50213B (sr) 2009-07-15
WO2002007683B1 (en) 2002-06-06
MXPA03000764A (es) 2003-06-04
IL154078A0 (en) 2003-07-31
HUP0301496A3 (en) 2011-05-30
PT1303249E (pt) 2004-06-30
IL193224A (en) 2013-12-31
HUP0301496A2 (hu) 2003-08-28
SK285949B6 (sk) 2007-11-02
DK1303249T3 (da) 2004-06-14
SK1022003A3 (en) 2003-10-07
JP2004504333A (ja) 2004-02-12
US7033578B2 (en) 2006-04-25
CZ295221B6 (cs) 2005-06-15
BRPI0112725B1 (pt) 2015-08-11
DE60102302D1 (de) 2004-04-15
YU4503A (sh) 2006-03-03
EP1303249B1 (en) 2004-03-10
AU2001272551A1 (en) 2002-02-05
ME00508B (me) 2011-10-10
US20040022831A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
BR0112725A (pt) Composição de verniz antimicótico para unha
BR0304289A (pt) Composições e artigos depilatórios e uso dos mesmos
BRPI0412029A (pt) formulações para microprojeções revestidas contendo contra-ìons não-voláteis
HK1093678A1 (en) Cosmetic composition containing nicotinamide and self tanning agent for use as self tanning composition
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
BRPI0409342A (pt) pelìcula de gel termorreversìvel homogênea, cápsulas moles, processos para fabricar as pelìculas de gel e para fabricar cápsulas moles contendo as pelìculas de gel, e, forma sólida
BR0102083A (pt) Uso de derivados de alfa-cetoenamina como ingredientes
BR0211039A (pt) Composição condicionadora para os cabelos e uso de uma composição condicionadora para os mesmos
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
PA8481301A1 (es) Derivados de 4,4-biarilpiperidina
BR0207147A (pt) Composição cosmética, processo cosmético capilar, kit que compreende pelo menos dois compartimentos, processo cosmético, uso de uma composição, uso de um kit e uso de um processo
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
WO2007022022A3 (en) Volumizing agents
BR0304288A (pt) Composições e artigos depilatórios e uso dos mesmos
RS20050925A (en) Nail restructuring compositions for topical application
BRPI0408499A (pt) solução aquosa estável de um fungicida de polieno
WO2003082193A3 (en) Suramin and derivatives thereof as topical microbicide and contraceptive
FR2803513B1 (fr) Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau
BRPI0900313A2 (pt) uso de um ou mais polìmeros catiÈnicos e/ou anfóteros
BR0114289A (pt) Composições para a limpeza da pele e o tratamento da acne
BR0113175A (pt) Derivados da quinolina como agentes antiinflamação
BR0003488A (pt) Composição fungicida e processo para preparar a mesma
WO2005011565A3 (fr) Vernis a ongles a action antimycosique
ES2190918T3 (es) Agente antiseptico/antifungico y composicion de linimento endermico que lo contiene.
BRPI0501241A (pt) composição cosmética, composição farmacêutica e processo para preparação das referidas composições

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 7/043 , A61K 7/48 , A61K 31/715

Ipc: A61K 8/42 (2006.01), A61K 8/49 (2006.01), A61K 8/7

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/07/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2679 DE 10-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.